Stockreport

Coloplast A/S - Full-Year Financial Results 2023/24 [Yahoo! Finance]

COLOPLAST AS SP/ADR  (CLPBY) 
NASDAQ:AMEX Investor Relations: coloplast.com/investor-relations
PDF Coloplast delivered Q4 organic growth of 8% and an EBIT margin of 26%, which was negatively impacted by extraordinary costs and currencies. Reported revenue in DKK grew [Read more]